Chemo-free combo provides potential first-line option for FLJune 12, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves venetoclax for CLL/SLL with or without del 17pJune 10, 2018Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Polatuzumab plus BR improves efficacy in DLBCLJune 8, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Single-agent acalabrutinib ‘impressive’ in patients with WMJune 6, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves first biosimilar pegfilgrastimJune 5, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Over 1100 new meds, vaccines being developed to treat cancerJune 4, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Older, cheaper drug formulation to remain availableMay 21, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive Lymphomas
Regimen can improve DFS in newly diagnosed T-ALLMay 17, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin Lymphoma
Umbralisib has ‘distinct’ safety profileMay 16, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Group calls on WHO to help fight HTLV-1May 12, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBlood Banking
Team identifies new prognostic factor for MFMay 10, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
‘Long-term benefits’ with nivolumab in cHLMay 9, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Drug granted fast track designations for FL, DLBCLMay 5, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA issues CRL for proposed biosimilar rituximabMay 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
FDA approves CAR T-cell therapy for lymphomaMay 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
